These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16543739)

  • 1. Safety and efficacy of oral slow release morphine for maintenance treatment in heroin addicts: a 6-month open noncomparative study.
    Vasilev GN; Alexieva DZ; Pavlova RZ
    Eur Addict Res; 2006; 12(2):53-60. PubMed ID: 16543739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
    Mitchell TB; White JM; Somogyi AA; Bochner F
    Addiction; 2004 Aug; 99(8):940-5. PubMed ID: 15265090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
    Bond AJ; Reed KD; Beavan P; Strang J
    Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of slow-release oral morphine on drug abusing habits in Austria].
    Beer B; Rabl W; Libiseller K; Giacomuzzi S; Riemer Y; Pavlic M
    Neuropsychiatr; 2010; 24(2):108-17. PubMed ID: 20605006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy.
    Eder H; Jagsch R; Kraigher D; Primorac A; Ebner N; Fischer G
    Addiction; 2005 Aug; 100(8):1101-9. PubMed ID: 16042640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men.
    Teoh SK; Mello NK; Mendelson JH; Kuehnle J; Gastfriend DR; Rhoades E; Sholar W
    J Clin Psychopharmacol; 1994 Feb; 14(1):15-27. PubMed ID: 8151000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
    Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM
    J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
    Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
    J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Slow-release morphine hydrochloride for maintenance therapy of opioid dependence].
    Kraigher D; Ortner R; Eder H; Schindler S; Fischer G
    Wien Klin Wochenschr; 2002 Nov; 114(21-22):904-10. PubMed ID: 12528322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative clinical study of the effects of the traditional Chinese medicine Jinniu capsules and lofexidine on acute heroin withdrawal symptoms.
    Shi J; Xu GZ; Liu TT; Wang X; Shen LY; Li J; Hao W; Chen HX; Li SX; Lu L
    Am J Drug Alcohol Abuse; 2008; 34(6):792-800. PubMed ID: 19016185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic moderate-to-severe non-malignant pain with polymer-coated extended-release morphine sulfate capsules.
    Nicholson B; Ross E; Weil A; Sasaki J; Sacks G
    Curr Med Res Opin; 2006 Mar; 22(3):539-50. PubMed ID: 16574037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts.
    Nava F; Caldiroli E; Premi S; Lucchini A
    J Addict Dis; 2006; 25(2):9-16. PubMed ID: 16785214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.